J. Johnson

发表

Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin

S. Bouchillon, D. Pontani, H. Washton, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)

D. Hoban, S. Bouchillon, M. Dowzicky, 2005 .

Identification of pioneer viridans streptococci in the oral cavity of human neonates.

M. Evans, M. Sheridan, S. Fitzsimmons, 1995, Journal of medical microbiology.

Worldwide Prevalence of Macrolide Resistance Genotypes among Streptococcus pneumoniae from 2004 to 2008

M. Hackel, D. Hoban, C. Lascols, 2009 .

A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniaeIsolates from across Europe, North America, and South America

J. Karlowsky, D. Hoban, L. Miller, 2000, Antimicrobial Agents and Chemotherapy.

Pioneer oral streptococci produce immunoglobulin A1 protease

M. Evans, M. Sheridan, S. Fitzsimmons, 1994, Infection and immunity.

Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.

D. Powars, R. Larsen, R. Francis, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disseminated candidiasis due to amphotericin B-resistant Candida albicans.

J. Conly, R. Rennie, J. Johnson, 1992, The Journal of infectious diseases.

Screening protocol for Torulopsis (Candida) glabrata

G. Land, J. Johnson, J. Rhodes, 1996, Journal of clinical microbiology.

The in Vitro Activity of Tigecycline and Antimicrobial Cross-Resistance Against Enterobacteriaceae Worldwide

M. Hackel, D. Hoban, S. Bouchillon, 2008 .

Phaeohyphomycotic cyst caused by a recently described species, Phaeoannellomyces elegans

K. Madden, N. Engleberg, M. Rinaldi, 1987, Journal of clinical microbiology.

Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study

D. Hoban, G. Zhanel, L. Miller, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Molecular Characterization of Gentamicin-Resistant Enterococci in the United States: Evidence of Spread from Animals to Humans through Food

J. R. Johnson, M. Zervos, J. Chow, 2003, Journal of Clinical Microbiology.

Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

P. Bradford, D. Hoban, S. Bouchillon, 2004, International journal of antimicrobial agents.

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2001, Diagnostic microbiology and infectious disease.

Further evaluation of the test for detection of antibody-coated bacteria in urine sediment

S. Jones, J. Johnson, 1977, Journal of clinical microbiology.

Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin

N. Baker, R. Warren, J. Johnson, 1985, Antimicrobial Agents and Chemotherapy.

Bordetella bronchiseptica in an AIDS patient cross-reacts with Legionella antisera

J. Johnson, V. Jimenez-Lucho, M. Shulman, 1994, Journal of clinical microbiology.

Comparative In Vitro Surveillance of Amoxicillin-Clavulanic Acid and Four Oral Comparators Against 21,232 Clinical Isolates from Europe

D. Hoban, G. Zhanel, L. Miller, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.

D. Hoban, L. Miller, J. Poupard, 2004, International journal of antimicrobial agents.

Possible Origin of the High Incidence of Clostridium botulinum Type E in an Inland Bay (Green Bay of Lake Michigan)

T. Bott, J. Johnson, E. M. Foster, 1968, Journal of bacteriology.

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2003, International journal of antimicrobial agents.